Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2078 (LINC02078) is a long non-coding RNA (lncRNA) transcribed from the human genome on chromosome 17 (chr17:79707266-79712317, hg38), consisting of two exons and spanning 4,237 base pairs[1][3][5]. It does not encode a protein, as supported by multiple coding potential analyses confirming its non-coding status[1]. Like other lincRNAs, LINC02078 may function in the regulation of gene expression, for example by serving as molecular scaffolds for chromatin-associated protein complexes or by modulating RNA-protein interactions[7]. While lincRNAs are increasingly studied for their roles in cancer and other diseases, there is currently no specific literature linking LINC02078 to any particular biological process, disease, or therapeutic targeting[1][3][5][7]. Its aliases include HP09025, CTD-2116F7.1, and its gene symbols or IDs in various databases such as HGNC and Ensembl.
Not applicable (no drugs or validated targeting mechanisms known for LINC02078)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2078 (LINC02078).